$58.78
0.70% today
NYSE, Dec 05, 05:16 pm CET
ISIN
US1101221083
Symbol
BMY
Sector
Industry

Bristol-Myers Squibb Stock price

$58.37
+2.92 5.27% 1M
+16.62 39.81% 6M
+7.06 13.76% YTD
+8.39 16.79% 1Y
+1.54 2.71% 3Y
-0.53 0.90% 5Y
-0.52 0.88% 10Y
NYSE, Closing price Wed, Dec 04 2024
-0.32 0.55%
ISIN
US1101221083
Symbol
BMY
Sector
Industry

Key metrics

Market capitalization $118.38b
Enterprise Value $161.75b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 11.72
EV/Sales (TTM) EV/Sales 3.41
P/S ratio (TTM) P/S ratio 2.50
P/B ratio (TTM) P/B ratio 6.91
Dividend yield 3.96%
Last dividend (FY23) $2.31
Revenue growth (TTM) Revenue growth 5.56%
Revenue (TTM) Revenue $47.44b
EBIT (operating result TTM) EBIT $8.36b
Free Cash Flow (TTM) Free Cash Flow $13.80b
Cash position $8.10b
EPS (TTM) EPS $-3.60
P/E forward negative
P/S forward 2.50
EV/Sales forward 3.41
Short interest 1.27%
Show more

Is Bristol-Myers Squibb a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,878 stocks worldwide.

Bristol-Myers Squibb Stock Analysis

Unlock Scores for Free

Analyst Opinions

28 Analysts have issued a Bristol-Myers Squibb forecast:

7x Buy
25%
20x Hold
71%
1x Sell
4%

Analyst Opinions

28 Analysts have issued a Bristol-Myers Squibb forecast:

Buy
25%
Hold
71%
Sell
4%

Financial data from Bristol-Myers Squibb

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
47,435 47,435
6% 6%
100%
- Direct Costs 20,935 20,935
12% 12%
44%
26,500 26,500
1% 1%
56%
- Selling and Administrative Expenses - -
- Research and Development Expense 9,818 9,818
6% 6%
21%
18,504 18,504
2% 2%
39%
- Depreciation and Amortization 10,145 10,145
3% 3%
21%
EBIT (Operating Income) EBIT 8,359 8,359
7% 7%
18%
Net Profit -7,258 -7,258
188% 188%
-15%

In millions USD.

Don't miss a Thing! We will send you all news about Bristol-Myers Squibb directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Bristol-Myers Squibb Stock News

Neutral
Seeking Alpha
2 days ago
Bristol-Myers Squibb Company (NYSE:BMY ) Citi's 2024 Global Healthcare Conference December 3, 2024 8:00 AM ET Company Participants Christopher Boerner - CEO and Board Chair David Elkins - EVP and CFO Conference Call Participants Geoff Meacham - Citi Mary Kate Davis - Citi Geoff Meacham Welcome to the first session of the First Annual Global Healthcare Conference at Citi. We're thrilled to be he...
Neutral
Business Wire
2 days ago
BOSTON--(BUSINESS WIRE)--AI Proteins, Inc., a biotechnology company that utilizes computational de novo protein design to create therapeutic miniproteins, today announced that it has entered a Research Collaboration and Option Agreement with Bristol Myers Squibb (NYSE: BMY) to discover and develop novel miniprotein-based therapeutics utilizing AI Proteins' powerful discovery platform. Under thi...
Neutral
The Motley Fool
3 days ago
Bristol-Myers Squibb (BMY -0.08%) is the kind of stock that potentially has a lot to offer to investors looking for wealth-building investments. With a large repertoire of medicines on the market, and a constant stream of programs approaching maturity and a shot at getting approved for sale, there's no question that the business will continue to create drugs that are in demand around the world.
More Bristol-Myers Squibb News

Company Profile

Bristol-Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. The firm offers chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. The company was founded in August 1933 and is headquartered in New York, NY.

Head office United States
CEO Christopher Boerner
Employees 34,100
Founded 1933
Website www.bms.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today